Literature DB >> 23055268

Extracellular signal-regulated kinase activation in the chronic constriction injury model of neuropathic pain in anaesthetized rats.

G S Borges1, E Berrocoso, A Ortega-Alvaro, J A Mico, F L Neto.   

Abstract

BACKGROUND: The role of extracellular signal-regulated kinases (ERKs) in nociception has been explored in the last years. While in spinal cord their activation is frequently correlated with pain or acute noxious stimuli, supraspinally, this association is not so evident and remains unclear. This study aims to evaluate ERK1/2 activation in the spinal cord and brainstem nuclei upon neuropathy and/or an additional mechanical stimulus.
METHODS: Acute noxious mechanical stimulation was applied in the left hindpaw of anaesthetized SHAM-operated and chronic constriction injured (CCI, neuropathic pain model) rats. Other SHAM or CCI rats did not receive any stimulus. Immunohistochemistry against the phosphorylated isoforms of ERK1/2 (pERK1/2) was performed in lumbar spinal cord and brainstem sections to assess ERK1/2 activation.
RESULTS: In the spinal cord, stimulation promoted an increase in pERK1/2 expression in the superficial dorsal horn of SHAM rats. No significant effects were caused by CCI alone. At supraspinal level, changes in ERK1/2 activation induced by CCI were observed in A5, locus coeruleus (LC), raphe obscurus (ROb), raphe magnus, dorsal raphe (DRN), lateral reticular and paragigantocellularis nucleus. CCI increased pERK1/2 expression in all these nuclei, with exception of LC, where a significant decrease was verified. Mechanical noxious stimulation of CCI rats decreased pERK1/2 expression in ROb and DRN, but no further changes were detected in either SHAM- or CCI-stimulated animals.
CONCLUSION: ERK1/2 are differentially activated in the spinal cord and in selected brainstem nuclei implicated in nociception, in response to an acute noxious stimulus and/or to a neuropathic pain condition.
© 2012 European Federation of International Association for the Study of Pain Chapters.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23055268     DOI: 10.1002/j.1532-2149.2012.00181.x

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  4 in total

1.  Glial cell line-derived neurotrophic factor-mediated enhancement of noradrenergic descending inhibition in the locus coeruleus exerts prolonged analgesia in neuropathic pain.

Authors:  M Kimura; A Sakai; A Sakamoto; H Suzuki
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

2.  Activation of Extracellular Signal-Regulated Kinases (ERK 1/2) in the Locus Coeruleus Contributes to Pain-Related Anxiety in Arthritic Male Rats.

Authors:  Gisela Borges; Cristina Miguelez; Fani Neto; Juan Antonio Mico; Luisa Ugedo; Esther Berrocoso
Journal:  Int J Neuropsychopharmacol       Date:  2017-06-01       Impact factor: 5.176

3.  Neuroendocrine signaling modulates specific neural networks relevant to migraine.

Authors:  Margarida Martins-Oliveira; Simon Akerman; Philip R Holland; Jan R Hoffmann; Isaura Tavares; Peter J Goadsby
Journal:  Neurobiol Dis       Date:  2017-01-17       Impact factor: 5.996

4.  Attenuation of the Diffuse Noxious Inhibitory Controls in Chronic Joint Inflammatory Pain Is Accompanied by Anxiodepressive-Like Behaviors and Impairment of the Descending Noradrenergic Modulation.

Authors:  Raquel Pereira-Silva; José Tiago Costa-Pereira; Raquel Alonso; Paula Serrão; Isabel Martins; Fani L Neto
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.